U.S. Pharmacogenomics Market Set for Explosive Growth, Projected to Reach USD 5.67 Billion by 2031

Allied Market Research has published a study report with the title U.S. Pharmacogenomics Market Size was valued at USD 2,463.9 Million in 2021 and is Anticipated to reach USD 5,676.1 Million by 2031, registering a CAGR of 8.7% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning …

U.S. Pharmacogenomics Market Size (USD 5,676.1 Million by 2031): Trends, Opportunities, and Challenges

Allied Market Research has published a study report with the title U.S. Pharmacogenomics Market Size was valued at USD 2,463.9 Million in 2021 and is Anticipated to reach USD 5,676.1 Million by 2031, registering a CAGR of 8.7% from 2022 to 2031. This report provides a comprehensive overview of the U.S. Pharmacogenomics Market, including an …

U.S. Pharmacogenomics Market Size to hit USD 5,676.1 Million by 2031 | CAGR of 8.7%

Pharmacogenomics is the study of how an individual’s genetic makeup affects their response to drugs. It involves analyzing a person’s genetic information to predict how they may respond to a particular medication, including how effective it may be and any potential side effects they may experience. This field combines the principles of pharmacology (the study …